Dr. Thompson is a California native who joined the Department of Medicine and the Pulmonary and Critical Care Unit at MGH in 1985. He directed the Pulmonary and Critical Care Fellowship training program until 1990 and the Medical Intensive Care Unit until 2011. He now the Director of Critical Care Translational Research in the Pulmonary and Critical Care Unit. His current patient care activities are focused solely on caring for critically ill patients and their families. He has been actively involved in teaching at Harvard Medical School where he is a Professor of Medicine. He has been an active clinical investigator for over 25 years. His primary research and academic interests involve managing clinical trials for patients with the Acute Respiratory Distress Syndrome (ARDS) or severe sepsis, investigating the molecular epidemiology of ARDS and sepsis, and developing and testing computerized bedside decision support tools.
Dr. Thompson is the Medical Director of the NHLBI-funded Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Coordinating Center where he coordinates randomized controlled trials for critically ill patients. In collaboration with Drs’ Christiani and Bajwa at MGH, Dr. Thompson is exploring the molecular epidemiology of ARDS susceptibility and ARDS and sepsis clinical outcomes. Dr Thompson is working with Dr. Michael Matthay at UCSF on the design and implementation of a Phase II trial of mesenchymal stem cells for the treatment of ALI and with Augustine Choi at the Brigham and Women’s Hospital on the design and implementation of a clinical trial of inhaled carbon monoxide as a potential therapeutic agent for ARDS.